Drug Pricing Initiatives: The fate of the reconciliation package that contains many of President Biden’s domestic policy initiatives, including with respect to drug pricing, remains in limbo as Democrats continue to debate the scope of the package. Competing approaches and priorities regarding drug pricing reform are a source of controversy within the Democratic party and face opposition from the Republican party. It is currently unclear when the reconciliation package will come to a vote.